| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocephalus | 2 | 2023 | 43 | 1.630 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2023 | 14 | 0.980 |
Why?
|
| Adenylate Kinase | 1 | 2023 | 18 | 0.850 |
Why?
|
| Neuroblastoma | 10 | 2003 | 52 | 0.780 |
Why?
|
| Glioblastoma | 4 | 2019 | 158 | 0.720 |
Why?
|
| Glioma | 5 | 2017 | 100 | 0.690 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 780 | 0.640 |
Why?
|
| Brain Neoplasms | 6 | 2017 | 308 | 0.600 |
Why?
|
| MicroRNAs | 4 | 2019 | 677 | 0.540 |
Why?
|
| Meningioma | 3 | 2012 | 60 | 0.520 |
Why?
|
| Neoplastic Stem Cells | 2 | 2015 | 205 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 2003 | 23 | 0.470 |
Why?
|
| Gene Deletion | 5 | 2012 | 308 | 0.470 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2012 | 6 | 0.460 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 1 | 2014 | 3 | 0.460 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2014 | 6 | 0.460 |
Why?
|
| Meningeal Neoplasms | 2 | 2012 | 59 | 0.440 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 317 | 0.410 |
Why?
|
| Alternative Splicing | 3 | 2012 | 127 | 0.400 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 20 | 0.380 |
Why?
|
| Proteins | 3 | 2023 | 751 | 0.360 |
Why?
|
| Cell Proliferation | 2 | 2019 | 984 | 0.360 |
Why?
|
| Mice | 14 | 2023 | 10849 | 0.330 |
Why?
|
| Cell Movement | 3 | 2011 | 451 | 0.330 |
Why?
|
| Cell Line, Tumor | 11 | 2019 | 1464 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 521 | 0.320 |
Why?
|
| Animals | 20 | 2023 | 20666 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 424 | 0.310 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2012 | 543 | 0.300 |
Why?
|
| Zebrafish | 5 | 2010 | 347 | 0.300 |
Why?
|
| Neoplasm Invasiveness | 4 | 2019 | 274 | 0.280 |
Why?
|
| Mutation | 5 | 2023 | 2609 | 0.270 |
Why?
|
| Neoplasms | 3 | 2014 | 1360 | 0.260 |
Why?
|
| Tumor Cells, Cultured | 10 | 2012 | 454 | 0.240 |
Why?
|
| Humans | 34 | 2023 | 63184 | 0.230 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2003 | 72 | 0.230 |
Why?
|
| Neuroectodermal Tumors | 1 | 2004 | 2 | 0.230 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 33 | 0.230 |
Why?
|
| Choroid Plexus | 1 | 2023 | 16 | 0.220 |
Why?
|
| Ependyma | 1 | 2023 | 9 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 129 | 0.200 |
Why?
|
| Transcription Factors | 1 | 2010 | 1514 | 0.190 |
Why?
|
| Cilia | 1 | 2023 | 153 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 341 | 0.180 |
Why?
|
| RNA, Messenger | 7 | 2010 | 1537 | 0.180 |
Why?
|
| ErbB Receptors | 2 | 2012 | 114 | 0.170 |
Why?
|
| Mice, Nude | 5 | 2012 | 273 | 0.160 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 1999 | 5 | 0.160 |
Why?
|
| Liquid Biopsy | 1 | 2019 | 5 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 15 | 0.160 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 36 | 0.160 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 19 | 0.160 |
Why?
|
| Leukemia | 1 | 1999 | 62 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 1999 | 108 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 1615 | 0.150 |
Why?
|
| Phenotype | 2 | 2015 | 1199 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2010 | 84 | 0.150 |
Why?
|
| Cell Adhesion | 1 | 2019 | 207 | 0.150 |
Why?
|
| Melatonin | 1 | 2018 | 66 | 0.150 |
Why?
|
| Serotonin | 1 | 2018 | 60 | 0.150 |
Why?
|
| Membrane Proteins | 3 | 2012 | 894 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 75 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 11 | 0.140 |
Why?
|
| Hexokinase | 1 | 2017 | 11 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1352 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2017 | 319 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2018 | 108 | 0.140 |
Why?
|
| Caspases | 4 | 2006 | 174 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2018 | 155 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 1184 | 0.130 |
Why?
|
| Disease Progression | 5 | 2012 | 1166 | 0.130 |
Why?
|
| Blotting, Western | 4 | 2012 | 611 | 0.130 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 468 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2018 | 139 | 0.130 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2016 | 31 | 0.130 |
Why?
|
| Brain | 2 | 2023 | 1552 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2001 | 49 | 0.120 |
Why?
|
| Sleep | 1 | 2018 | 224 | 0.120 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 878 | 0.120 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2014 | 8 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 18 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2014 | 16 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 17 | 0.110 |
Why?
|
| Protein Subunits | 1 | 2014 | 166 | 0.110 |
Why?
|
| Cell Nucleolus | 1 | 2014 | 70 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 65 | 0.110 |
Why?
|
| Loss of Heterozygosity | 3 | 2010 | 24 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 208 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2014 | 276 | 0.100 |
Why?
|
| Alcoholism | 1 | 2016 | 318 | 0.100 |
Why?
|
| Homozygote | 3 | 2001 | 124 | 0.100 |
Why?
|
| Apoptosis | 3 | 2010 | 1075 | 0.100 |
Why?
|
| DNA, Neoplasm | 3 | 2001 | 58 | 0.100 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2012 | 9 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2003 | 199 | 0.100 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2012 | 24 | 0.090 |
Why?
|
| DNA Mutational Analysis | 2 | 2003 | 196 | 0.090 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 87 | 0.090 |
Why?
|
| Sequence Tagged Sites | 2 | 2001 | 4 | 0.090 |
Why?
|
| Leukemia, Myeloid | 2 | 2002 | 35 | 0.090 |
Why?
|
| RNA Interference | 2 | 2014 | 618 | 0.090 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 28 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2010 | 68 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 47 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 165 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1200 | 0.080 |
Why?
|
| Adult | 3 | 2023 | 16734 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 765 | 0.080 |
Why?
|
| Middle Aged | 3 | 2023 | 17474 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 48 | 0.080 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 7 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 49 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 140 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2010 | 98 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2009 | 67 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 189 | 0.080 |
Why?
|
| DNA Methylation | 4 | 2010 | 292 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 490 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 238 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2006 | 178 | 0.070 |
Why?
|
| Transfection | 1 | 2010 | 692 | 0.070 |
Why?
|
| Male | 9 | 2019 | 29724 | 0.070 |
Why?
|
| Zebrafish Proteins | 2 | 2006 | 158 | 0.070 |
Why?
|
| Animals, Genetically Modified | 2 | 2006 | 290 | 0.070 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 2003 | 16 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 892 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 84 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2010 | 642 | 0.060 |
Why?
|
| Fish Proteins | 1 | 2006 | 9 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 674 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2003 | 1597 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2003 | 1998 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 67 | 0.060 |
Why?
|
| Chromosome Aberrations | 2 | 2003 | 67 | 0.060 |
Why?
|
| Cytosol | 1 | 2006 | 179 | 0.060 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2004 | 1 | 0.060 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2004 | 10 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2001 | 34 | 0.060 |
Why?
|
| Rhabdomyosarcoma | 2 | 2003 | 16 | 0.060 |
Why?
|
| Sarcoma, Ewing | 2 | 2003 | 14 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 365 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2003 | 186 | 0.050 |
Why?
|
| Tumor Protein p73 | 2 | 2001 | 4 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 12 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 187 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 309 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 52 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 279 | 0.050 |
Why?
|
| Gene Expression | 2 | 2010 | 838 | 0.050 |
Why?
|
| Time Factors | 1 | 2010 | 3757 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2002 | 8 | 0.050 |
Why?
|
| Neurons | 2 | 2006 | 923 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2002 | 96 | 0.050 |
Why?
|
| Chromosome Banding | 1 | 2001 | 13 | 0.050 |
Why?
|
| Allelic Imbalance | 1 | 2001 | 7 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2001 | 10 | 0.050 |
Why?
|
| Cell Line | 2 | 2012 | 2037 | 0.050 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2001 | 6 | 0.050 |
Why?
|
| Molecular Motor Proteins | 1 | 2001 | 33 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2001 | 42 | 0.050 |
Why?
|
| Genome, Human | 1 | 2003 | 237 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2001 | 39 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 35 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 394 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 383 | 0.040 |
Why?
|
| Insulin | 1 | 2004 | 687 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2001 | 109 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2001 | 150 | 0.040 |
Why?
|
| Microtubules | 1 | 2001 | 209 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2014 | 381 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 293 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2006 | 143 | 0.040 |
Why?
|
| Point Mutation | 1 | 2000 | 166 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 168 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2011 | 2156 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 135 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 192 | 0.040 |
Why?
|
| Hemocyanins | 1 | 1999 | 23 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2019 | 16 | 0.040 |
Why?
|
| Female | 6 | 2019 | 32722 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 1999 | 22 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1999 | 51 | 0.040 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1999 | 103 | 0.040 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 34 | 0.040 |
Why?
|
| Base Sequence | 1 | 2001 | 1334 | 0.040 |
Why?
|
| Immunoblotting | 1 | 1999 | 204 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 72 | 0.040 |
Why?
|
| Reference Values | 1 | 1999 | 335 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 202 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1999 | 73 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 332 | 0.040 |
Why?
|
| Bone Marrow | 1 | 1999 | 178 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 278 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 114 | 0.040 |
Why?
|
| Regeneration | 1 | 2018 | 96 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 280 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 324 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 701 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 297 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1999 | 192 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2019 | 390 | 0.030 |
Why?
|
| Presenilin-2 | 2 | 2006 | 20 | 0.030 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 8 | 0.030 |
Why?
|
| Genes, myc | 1 | 1996 | 18 | 0.030 |
Why?
|
| Prognosis | 3 | 2010 | 1738 | 0.030 |
Why?
|
| Gene Amplification | 1 | 1996 | 24 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2017 | 394 | 0.030 |
Why?
|
| Aged | 3 | 2017 | 14331 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 2006 | 150 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 2014 | 16 | 0.030 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Actomyosin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 2014 | 37 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 33 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2014 | 46 | 0.030 |
Why?
|
| AC133 Antigen | 1 | 2012 | 6 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 663 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 126 | 0.020 |
Why?
|
| Expressed Sequence Tags | 2 | 2002 | 28 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 46 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2003 | 1986 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2190 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2011 | 28 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 109 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 487 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 937 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2011 | 37 | 0.020 |
Why?
|
| Infant | 3 | 2003 | 1648 | 0.020 |
Why?
|
| Caspase 9 | 2 | 2001 | 23 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 187 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 347 | 0.020 |
Why?
|
| Iron | 1 | 2011 | 146 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2002 | 289 | 0.020 |
Why?
|
| Caspase 8 | 2 | 2001 | 64 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 669 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 65 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 60 | 0.020 |
Why?
|
| RNA | 2 | 2003 | 423 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 95 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1608 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 261 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 296 | 0.020 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2009 | 39 | 0.020 |
Why?
|
| DNA | 2 | 2003 | 835 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 577 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 451 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 455 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 664 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 908 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 400 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 491 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 573 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 234 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 47 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2006 | 37 | 0.020 |
Why?
|
| Biopsy | 1 | 2007 | 433 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 50 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 130 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2006 | 77 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 216 | 0.020 |
Why?
|
| Body Patterning | 1 | 2006 | 82 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5621 | 0.020 |
Why?
|
| Indoles | 1 | 2006 | 110 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2006 | 103 | 0.010 |
Why?
|
| Child | 3 | 2000 | 4518 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 6595 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 864 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2003 | 10 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 55 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2003 | 293 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 198 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 5 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2158 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 670 | 0.010 |
Why?
|
| Caspase 10 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2001 | 14 | 0.010 |
Why?
|
| Genes, Neoplasm | 1 | 2001 | 24 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2001 | 31 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2001 | 32 | 0.010 |
Why?
|
| Synaptic Vesicles | 1 | 2001 | 25 | 0.010 |
Why?
|
| Axonal Transport | 1 | 2001 | 32 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2001 | 89 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2002 | 260 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 195 | 0.010 |
Why?
|
| Exons | 1 | 2001 | 199 | 0.010 |
Why?
|
| CpG Islands | 1 | 2001 | 216 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 319 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3035 | 0.010 |
Why?
|
| Hippocampus | 1 | 2001 | 270 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 1999 | 26 | 0.010 |
Why?
|
| Gene Duplication | 1 | 1999 | 34 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 721 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 738 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2001 | 753 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 671 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2001 | 2110 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1996 | 128 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1996 | 503 | 0.010 |
Why?
|
| Adolescent | 1 | 1999 | 6227 | 0.000 |
Why?
|